Open-access Impact of renal failure on in-hospital outcomes after coronary artery bypass surgery

Abstracts

BACKGROUND: Chronic kidney disease (CKD) is a predictor of increased mortality in patients undergoing coronary artery bypass surgery (CABG). OBJECTIVE: To evaluate the characteristics and predictors of increased mortality in the CKD population submitted to CABG. To compare in-hospital outcomes between patients with and without CKD, and with and without development of acute renal failure (ARF). METHODS: Retrospective analysis of a prospective database of all isolated CABG performed in a single public tertiary hospital from 1999 to 2007. CKD was considered when creatinine > 1.5 mg/dl. Clinical characteristics, mortality and post-operative complications were evaluated according to renal function. RESULTS: Of 3,890 patients, 362 (9.3%) had CKD. This population was older, presented grater prevalence of hypertension, left ventricular dysfunction, previous stroke, peripheral vascular disease and three-vessel disease. In-hospital outcomes revealed greater incidence of stroke (5.5% vs 2.1%), atrial fibrillation (16 vs 8.3%), low cardiac ouput syndrome (14.4% vs 8.5%), longer stay in intensive care unit (4.04 vs 2.83 days), and greater mortality (10.5% vs 3.8%). Logistic regression: female gender, smoking, diabetes and peripheral vascular disease were associated with higher in-hospital mortality within the CKD group. Patients who did not develop post-operative ARF presented 3.5% mortality; non-dialytic ARF: 35.4%; dialytic ARF: 66.7% mortality. Mortality was directly related to the stage of CKD, according to glomerular filtration rate. CONCLUSION: CKD patients submitted to CABG represent a high risk population, with increased incidence of complications and mortality. Post-operative ARF is a strong in-hospital mortality predictor. Glomerular filtration rate was inversely related to mortality.

Renal insufficiency, chronic; myocardial revascularization; morbidity; prognostic; lenght of stay; intensive care units


FUNDAMENTO: A doença renal crônica (DRC) é um marcador de mortalidade na cirurgia de revascularização miocárdica (CRM). OBJETIVO: Avaliar em pacientes com DRC submetidos a CRM as características clínicas e os marcadores de morbimortalidade hospitalar; comparar a evolução intra-hospitalar entre os grupos com e sem DRC, e com e sem desenvolvimento de insuficiência renal aguda (IRA). MÉTODOS: Foram analisadas as CRM isoladas realizadas num hospital público cardiológico de 1999 a 2007. Considerado disfunção renal quando creatinina > 1,5 mg/dl. Avaliaram-se características clínicas, mortalidade e complicações pós-operatórias conforme a função renal. RESULTADOS: De 3.890 pacientes, 362 (9,3%) tinham DRC. Esse grupo apresentava idade mais avançada, maior prevalência de hipertensão, disfunção ventricular esquerda, acidente vascular encefálico (AVE) prévio, doença arterial periférica e triarteriais. No pós-operatório, apresentou maior incidência de AVE (5,5% vs 2,1%), fibrilação atrial (16 vs 8,3%), síndrome de baixo débito cardíaco (14,4% vs 8,5%), maior tempo de internação na unidade de terapia intensiva (4,04 vs 2,83 dias), e maior mortalidade intra-hospitalar (10,5% vs 3,8%). Sexo feminino, tabagismo, diabete e doença vascular periférica e/ou carotídea associaram-se com maior mortalidade no grupo DRC. Pacientes que não desenvolveram IRA pós-operatória apresentaram 3,5% de mortalidade; grupo IRA não dialítica: 35,4%; grupo IRA dialítica: 66,7%. Calculando-se a taxa de filtração glomerular, observou-se aumento da mortalidade conforme o aumento da classe da DRC. CONCLUSÃO: Pacientes com DRC submetidos a CRM constituem população de elevado risco, apresentando maior morbimortalidade. IRA pós-operatória é importante marcador de mortalidade. A taxa de filtração glomerular foi inversamente relacionada com mortalidade.

Insuficiência renal crônica; revascularização miocárdica; morbidade; prognóstico; tempo de internação; unidade de terapia intensiva


Instituto Dante Pazzanese de Cardiologia, São Paulo, SP - Brazil

Mailing address

ABSTRACT

BACKGROUND: Chronic kidney disease (CKD) is a predictor of increased mortality in patients undergoing coronary artery bypass surgery (CABG).

OBJECTIVE: To evaluate the characteristics and predictors of increased mortality in the CKD population submitted to CABG. To compare in-hospital outcomes between patients with and without CKD, and with and without development of acute renal failure (ARF).

METHODS: Retrospective analysis of a prospective database of all isolated CABG performed in a single public tertiary hospital from 1999 to 2007. CKD was considered when creatinine > 1.5 mg/dl. Clinical characteristics, mortality and post-operative complications were evaluated according to renal function.

RESULTS: Of 3,890 patients, 362 (9.3%) had CKD. This population was older, presented grater prevalence of hypertension, left ventricular dysfunction, previous stroke, peripheral vascular disease and three-vessel disease. In-hospital outcomes revealed greater incidence of stroke (5.5% vs 2.1%), atrial fibrillation (16 vs 8.3%), low cardiac ouput syndrome (14.4% vs 8.5%), longer stay in intensive care unit (4.04 vs 2.83 days), and greater mortality (10.5% vs 3.8%). Logistic regression: female gender, smoking, diabetes and peripheral vascular disease were associated with higher in-hospital mortality within the CKD group. Patients who did not develop post-operative ARF presented 3.5% mortality; non-dialytic ARF: 35.4%; dialytic ARF: 66.7% mortality. Mortality was directly related to the stage of CKD, according to glomerular filtration rate.

CONCLUSION: CKD patients submitted to CABG represent a high risk population, with increased incidence of complications and mortality. Post-operative ARF is a strong in-hospital mortality predictor. Glomerular filtration rate was inversely related to mortality.

Keywords: Renal insufficiency, chronic; myocardial revascularization/mortality; morbidity; prognostic; lenght of stay; intensive care units.

Introduction

Chronic kidney disease (CKD) is a risk marker in patients with coronary artery disease (CAD)1. In patients undergoing coronary artery bypass grafting (CABG), CKD is associated with longer hospitalization and higher rates of hospital morbidity and mortality2-4. CKD, even from mild to moderate, implies an increase in mortality after CABG. Prognosis is even more reserved in patients with chronic kidney disease in the terminal phase5. Moreover, the need for dialysis procedures in the postoperative period is associated with significant elevation of hospital mortality, and its incidence is higher in CKD patients prior to cardiac surgery4,6,7.

Patients with CKD are older, have a higher prevalence of diabetes and hypertension, and these factors are also associated with higher operative mortality. Despite this association, it is believed that chronic kidney disease is an independent marker of mortality in the long term8. The scores of surgical risk usually use CKD as a marker of increased surgical risk9-11.

Although renal failure is a known major risk factor in patients undergoing CABG, the characteristics of patients with CKD are poorly known, as well as factors associated with increased morbidity and mortality in this specific group of patients.

Objective

This study aimed to evaluate the impact of primary chronic renal disease in morbidity (length of stay in the ICU, atrial fibrillation, low cardiac output syndrome and cerebrovascular accident) and hospital mortality after CABG and to identify factors associated with increased hospital mortality in the group with CKD. The secondary objectives were to assess the effect of acute renal failure after surgery on hospital mortality; analyze the relationship between hemoglobin and creatinine levels preoperatively; evaluate the importance of using the glomerular filtration rate calculated by the Cockcroft-Gault formula12, defining the mortality found for each class of CKD.

Methods

We performed a retrospective analysis of a database collected prospectively from January 1, 1999 to December 31, 2007, of all isolated CABGs in a tertiary cardiac education institution. Surgeries with associated procedures, such as prostheses and valvuloplasty, correction of aneurysms, and carotid endarterectomy were excluded. This study was approved by the local ethics and research committee.

Hospital operative mortality as defined as the one occurring within 30 days from the date of surgery or during hospitalization, regardless of the time elapsed since the operation13. We evaluated the clinical, laboratory, hemodynamic, operative and postoperative data.

CKD was considered the presence of preoperative serum creatinine > 1.5 mg/dl; ARF was considered high postoperative plasma creatinine > 50% compared to baseline, or the need for dialysis postoperatively in patients who failed to perform it before the CABG.

We used the preoperative risk model European System for Cardiac Operative Risk Evaluation (EuroSCORE)11 to calculate the risk of each patient.

Was also calculated creatinine clearance by the Cockcroft-Gault formula12 for all patients.

For comparisons of categorical variables we used the chi-square test, and for continuous variables, Student t test. p values < 0.05 were considered statistically significant. Logistic regression models were used considering mortality as the dependent variable13.

We compared non-CKD and CKD groups to their baseline preoperative clinical characteristics, length of stay in days in the Intensive Care Unit, and the occurrence of complications (atrial fibrillation, low cardiac output syndrome and cerebrovascular accident) and in-hospital death during postoperative evolution.

In the CKD group, we analyzed the correlation between the values of creatinine and serum hemoglobin on the earliest date of surgery, with a maximum interval of 30 days.

ROC curves were constructed for numerical variables referring to the measurement of renal function and serum hemoglobin, compared with mortality, in order to determine the level considered as cutoff points for markers of hospital mortality.

Results

Out of the 3,890 patients undergoing isolated CABG in the period, 362 (9.3%) had CKD. Table 1 describes the baseline characteristics of each group. Patients with CKD are a higher risk group, showing a significantly higher EuroSCORE compared with the group without CKD. The highest score was not justified only by the presence of CKD.

Table 2 shows the highest rates of complications of the CKD group.

In order to identify factors related to death in the CKD group, we used logistic regression analysis (Table 3). Female sex, smoking, diabetes, peripheral vascular disease and/or carotid artery were associated with increased mortality.

The development of acute renal failure (ARF) resulted in a significant increase in mortality by 3.5% in the group who did not develop ARF compared to 35.4% in the group that developed ARF not requiring dialysis postoperatively and 66.7% in the ARF group that required dialysis therapy (p = 0.001).

Lower levels of hemoglobin after surgery correlated with higher severity of renal dysfunction, as measured by serum creatinine (Rho correlation = -0.368, p < 0.001). In the CKD group, mean creatinine was 2.1 mg/dl (± 0.6), and mean hemoglobin level was 12.3 mg/dl (± 1.9 mg/dl).

When renal dysfunction is measured by the Cockcroft-Gault formula12 (Table 4) to calculate the glomerular filtration rate, we found a higher prevalence of Class III renal dysfunction, and increased mortality with increasing CKD class14.

It was not possible to detect cutoff values of serum creatinine or creatinine clearance by ROC analysis from which there was significant increase in the death outcome.

Discussion

This analysis of 3,890 patients undergoing CABG over six years (1999-2007) found 362 (9.3%) patients with CKD, with higher prevalence of males, older age, higher prevalence of hypertension, previous cerebrovascular accident, peripheral arterial disease, triple vessel coronary artery disease and left ventricular dysfunction, and hence a higher EuroSCORE.

Patients with CKD had higher rates of complications and mortality, and in this group, after adjusting for risk factors, correlated with higher female mortality, smoking, diabetes and peripheral arterial disease and/or carotid artery disease. Acute renal failure in the postoperative period was associated with a significant increase in mortality, especially when dialysis was needed.

In our sample, we found a prevalence of CKD of 9.3% similar to that described by Zaker et al15, of 10.4%. We have set the value above 1.5 mg/dl as CKD. Other authors define values above 1.2 mg/dl, as used by Jyrala et al16, who have found increased mortality from this value of creatinine before the surgery and other authors set values of 2.26 mg/dl (< 200 micromol/l)15 as a cut-off value for DRC, which is the same used by the EuroSCORE11. Values set by glomerular filtration rate are more reliable for evaluation of renal function, being used by some authors when smaller than 60 ml/min17.

Hemoglobin and creatinine levels after surgery showed an inverse relationship, showing a higher incidence of anemia according to worsened renal function, but the identification of a cutoff point for increased mortality by the ROC curve was not possible. This may explain why there is a systematic correction of anemia before and during surgery, usually by blood transfusion, making it difficult to measure anemia effectively; consequently, anemia was not associated with mortality.

The greater number of comorbidities in the CKD group is a similar finding to previous studies, compared to information from large databases, such as the database of the STS (Society of Thoracic Surgeons National Adult Cardiac)3 and the database of the state of California18. Patients with CKD have a higher prevalence of risk factors associated with increased operative mortality defined by Jones et al9 such as advanced age, female sex, peripheral arterial disease, left ventricular dysfunction. The EuroSCORE19 includes renal failure as a risk factor for mortality, as well as age, female sex, peripheral arterial disease and left ventricular dysfunction. The STS database points to severe renal dysfunction as an important marker of hospital mortality, involving severe CKD and dependence on dialysis with a risk ratio from 2.9 to 3.8 on mortality3.

In this study, a significant number of patients was evaluated, revealing a mortality of 3.8% in the group without CKD and a significantly higher mortality of 10.5% (p < 0.001) in patients with CKD. Piegas et al20 describe a national mortality rate for CABG of 6.22%, but these data refer to total revascularization, without exclusion of surgeries with associated procedures, which interfere in the analysis of mortality.

The development of ARF in the postoperative period was associated with significant increases in mortality, especially when hemodialysis was necessary. Even small changes in renal function postoperatively are associated with significant elevations in mortality, according to studies by Litmathe et al21 and Machado et al22. The cardiopulmonary bypass (CPB) was higher in the CKD group, probably related to a greater number of vessels involved. This greater time was identified by logistic regression analysis related to death. Diez et al23 associated with a shorter duration of CPB to a smaller rate of occurrence of renal failure immediately after CABG. In our sample there were few patients operated without CPB, thus this factor was not analyzed. Di Mauro et al24 evaluated CABG with and without CPB in patients with CKD, defined as creatinine > 1.5 mg/dl, and found no differences between the different strategies with respect to worsening renal function.

Until recently, most studies have used only creatinine to define CKD. The Brazilian Society of Nephrology14 has set a five-level classification for renal failure, based on the glomerular filtration rate (GFR). According to these findings, there was a higher incidence of class III renal failure, and mortality progressively higher according to worsening renal function was found. Swart et al25 found a correlation between GFR and lower risk of developing acute renal failure after surgery, as well as Moore et al26, who found also a correlation of GFR with time of hospitalization. Lopes et al27, in turn, followed, for five years, patients with multivessel coronary disease under various therapies, and described a significantly higher mortality rate in the group with moderate renal impairment, compared with mild renal dysfunction and normal renal function according to the glomerular filtration rate27. Our study also demonstrated this inverse association between GFR and mortality.

Conclusions

Patients with CKD who underwent CABG constitute a higher risk population, evolving postoperatively with higher rates of complications and in-hospital mortality. In this group, female sex, smoking, diabetes and peripheral vascular disease and/or carotid artery disease were associated with higher mortality after surgery. The development of ARF in the postoperative period was associated with significant increases in mortality, especially when hemodialysis was necessary. The severity of anemia was directly related to the severity of renal dysfunction. When renal dysfunction was calculated by the glomerular filtration rate (Cockcroft-Gault formula), we found a hospital mortality progressively higher according to the worsening of renal function.

Potential Conflict of Interest

No potential conflict of interest relevant to this article was reported.

Sources of Funding

There were no external funding sources for this study.

Study Association

This study is not associated with any post-graduation program.

References

References

  • 1. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007;116(1):85-97.
  • 2. Anderson RJ, O'Brien M, MaWhinney S, VillaNueva CB, Moritz TE, Sethi GK, et al. Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery. VA Cooperative Study #5. Kidney Int. 1999;55(3):1057-62.
  • 3. Cooper WA, O'Brien SM, Thourani VH, Guyton RA, Bridges CR, Szczech LA, et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation. 2006;113(8):1063-70.
  • 4. Samuels LE, Sharma S, Morris RJ, Kuretu ML, Grunewald KE, Strong MD 3rd, III, et al. Coronary artery bypass grafting in patients with chronic renal failure: A reappraisal. J Card Surg. 1996;11(2):128-33.
  • 5. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med. 1998;128(3):194-203.
  • 6. Bianco AC, Timerman A, Paes AT, Gun C, Ramos RF, Freire RB, et al. [Prospective risk analysis in patients submitted to myocardial revascularization surgery]. Arq Bras Cardiol. 2005;85(4):254-61.
  • 7. Nakayama Y, Sakata R, Ura M, Itoh T. Long-term results of coronary artery bypass grafting in patients with renal insufficiency. Ann Thorac Surg. 2003;75(2):496-500.
  • 8. van de Wal RM, van Brussel BL, Voors AA, Smilde TD, Kelder JC, van Swieten HA, et al. Mild preoperative renal dysfunction as a predictor of long-term clinical outcome after coronary bypass surgery. J Thorac Cardiovasc Surg. 2005;129(2):330-5.
  • 9. Jones RH, Hannan EL, Hammermeister KE, Delong ER, O'Connor GT, Luepker RV, et al. Identification of preoperative variables needed for risk adjustment of short-term mortality after coronary artery bypass graft surgery. The Working Group Panel on the Cooperative CABG Database Project. J Am Coll Cardiol. 1996;28(6):1478-87.
  • 10. Ranucci M, Castelvecchio S, Menicanti L, Frigiola A, Pelissero G. Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony. Circulation. 2009;119(24):3053-61.
  • 11. Roques F, Nashef SA, Michel P, Gauducheau E, de VC, Baudet E, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg. 1999;15(6):816-22.
  • 12. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41.
  • 13. Ferguson TB Jr, Dziuban SW Jr, Edwards FH, Eiken MC, Shroyer AL, Pairolero PC, et al. The STS National Database: current changes and challenges for the new millennium. Committee to Establish a National Database in Cardiothoracic Surgery, The Society of Thoracic Surgeons. Ann Thorac Surg. 2000;69(3):680-91.
  • 14. Romao Jr JE. Doença renal crônica: definição, epidemiologia e classificação. J Bras Nefrol. 2004;26(supl. 1):1-3.
  • 15. Zakeri R, Freemantle N, Barnett V, Lipkin GW, Bonser RS, Graham TR, et al. Relation between mild renal dysfunction and outcomes after coronary artery bypass grafting. Circulation. 2005;112(9 Suppl):I270-5.
  • 16. Jyrala A, Weiss RE, Jeffries RA, Kay GL. Effect of mild renal dysfunction (s-crea 1.2-2.2 mg/dl) on presentation characteristics and short- and long-term outcomes of on-pump cardiac surgery patients. Interact Cardiovasc Thorac Surg. 2010;10(5):777-82.
  • 17. Mehta RH, Hafley GE, Gibson CM, Harrington RA, Peterson ED, Mack MJ, et al. Influence of preoperative renal dysfunction on one-year bypass graft patency and two-year outcomes in patients undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2008;136(5):1149-55.
  • 18. Yeo KK, Li Z, Yeun JY, Amsterdam E. Severity of chronic kidney disease as a risk factor for operative mortality in nonemergent patients in the California coronary artery bypass graft surgery outcomes reporting program. Am J Cardiol. 2008;101(9):1269-74.
  • 19. Nashef SA, Roques F, Hammill BG, Peterson ED, Michel P, Grover FL, et al. Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg. 2002;22(1):101-5.
  • 20. Piegas LS, Bittar OJ, Haddad N. Myocardial revascularization surgery (MRS): results from national health system (SUS). Arq Bras Cardiol. 2009;93(5):555-60.
  • 21. Litmathe J, Kurt M, Feindt P, Gams E, Boeken U. The impact of pre- and postoperative renal dysfunction on outcome of patients undergoing coronary artery bypass grafting (CABG). Thorac Cardiovasc Surg. 2009;57(8):460-3.
  • 22. Machado MN, Miranda RC, Takakura IT, Palmegiani E, Santos CA, Oliveira MA, et al. Acute kidney injury after on-pump coronary artery bypass graft surgery. Arq Bras Cardiol. 2009;93(3):247-52.
  • 23. Diez C, Haneya A, Brunger F, Philipp A, Hirt S, Ruppecht L, et al. Minimized extracorporeal circulation cannot prevent acute kidney injury but attenuates early renal dysfunction after coronary bypass grafting. ASAIO J. 2009;55(6):602-7.
  • 24. Di MM, Gagliardi M, Iaco AL, Contini M, Bivona A, Bosco P, et al. Does off-pump coronary surgery reduce postoperative acute renal failure? The importance of preoperative renal function. Ann Thorac Surg. 2007;84(5):1496-502.
  • 25. Swart MJ, Bekker AM, Malan JJ, Meiring A, Swart Z, Joubert G. The simplified modification of diet in renal disease equation as a predictor of renal function after coronary artery bypass graft surgery. Cardiovasc J Afr. 2010;21(1):9-12.
  • 26. Moore EM, Simpson JA, Tobin A, Santamaria J. Preoperative estimated glomerular filtration rate and RIFLE-classified postoperative acute kidney injury predict length of stay post-coronary bypass surgery in an Australian setting. Anaesth Intensive Care. 2010;38(1):113-21.
  • 27. Lopes NH, da Silva PF, Pereira A, Garzillo CL, Ferreira JF, Stolf N, et al. Mild chronic kidney dysfunction and treatment strategies for stable coronary artery disease. J Thorac Cardiovasc Surg. 2009;137(6):1443-9.
  • Impact of renal failure on in-hospital outcomes after coronary artery bypass surgery
    Roberto Ramos Barbosa; Priscila Feitoza Cestari; Julhano Tiago Capeletti; Gustavo Magnus T. L. S. R. Peres; Tania L. Pozzo Ibañez; Patrícia Viana da Silva; Jorge A. Farran; Vivian Lerner Amato; Pedro Silvio Farsky
  • Publication Dates

    • Publication in this collection
      17 June 2011
    • Date of issue
      Sept 2011

    History

    • Reviewed
      29 Nov 2010
    • Received
      14 Nov 2010
    • Accepted
      23 Feb 2011
    location_on
    Sociedade Brasileira de Cardiologia - SBC Avenida Marechal Câmara, 160, sala: 330, Centro, CEP: 20020-907, (21) 3478-2700 - Rio de Janeiro - RJ - Brazil, Fax: +55 21 3478-2770 - São Paulo - SP - Brazil
    E-mail: revista@cardiol.br
    rss_feed Stay informed of issues for this journal through your RSS reader
    Acessibilidade / Reportar erro